Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 291

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

Open access
Stumpf, Julian, Siepmann, Torsten, Lindner, Tom, Karger, Claudia, Schwöbel, Jörg, Anders, Leona, Faulhaber-Walter, Robert, Schewe, Jens, Martin, Heike, Schirutschke, Holger, Barnett, Kerstin, Hüther, Jan, Müller, Petra, Langer, Torsten, Pluntke, Thilo, Anding-Rost, Kirsten, Meistring, Frank, Stehr, Thomas, Pietzonka, Annegret, Escher, Katja, Cerny, Simon, Rothe, Hansjörg, Pistrosch, Frank, Seidel, Harald, Paliege, Alexander, Beige, Joachim, Bast, Ingolf, Steglich, Anne, Gembardt, Florian, Kessel, Friederike, Kröger, Hannah, Arndt, Patrick, Sradnick, Jan, Frank, Kerstin, Klimova, Anna, Mauer, René, Grählert, Xina, Anft, Moritz, Blazquez-Navarro, Arturo, Westhoff, Timm H, Stervbo, Ulrik, Tonn, Torsten, Babel, Nina, Hugo, Christian·2021·The Lancet Regional Health - Europe

Abstract

Dialysis and kidney transplant patients are vulnerable populations for COVID-19 related disease and mortality. We conducted a prospective study exploring the eight week time course of specific cellular (interferon-γ release assay and flow cytometry) or/and humoral immune responses (ELISA) to SARS-CoV-2 boost vaccination in more than 3100 participants including medical personnel, dialysis patients and kidney transplant recipients using mRNA vaccines BNT162b2 or mRNA-1273. SARS-CoV-2-vaccination induced seroconversion efficacy in dialysis patients was similar to medical personnel (> 95%), but markedly impaired in kidney transplant recipients (42%). T-cellular immunity largely mimicked humoral results. Major risk factors of seroconversion failure were immunosuppressive drug number and type (belatacept, MMF-MPA, calcineurin-inhibitors) as well as vaccine type (BNT162b2 mRNA). Seroconversion rates induced by mRNA-1273 compared to BNT162b2 vaccine were 97% to 88% (p < 0.001) in dialysis and 49% to 26% in transplant patients, respectively. Specific IgG directed against the new binding domain of the spike protein (RDB) were significantly higher in dialysis patients vaccinated by mRNA-1273 (95%) compared to BNT162b2 (85%, p < 0.001). Vaccination appeared safe and highly effective demonstrating an almost complete lack of symptomatic COVID-19 disease after boost vaccination as well as ceased disease incidences during third pandemic wave in dialysis patients. Dialysis patients exhibit a remarkably high seroconversion rate of 95% after boost vaccination, while humoral response is impaired in the majority of transplant recipients. Immunosuppressive drug number and type as well as vaccine type (BNT162b2) are major determinants of seroconversion failure in both dialysis and transplant patients suggesting immune monitoring and adaption of vaccination protocols.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.lanepe.2021.100178

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 291

Metadata

Authors
Stumpf, J., Siepmann, T., Lindner, T., Karger, C., Schwöbel, J., Anders, L., Faulhaber-Walter, R., Schewe, J., Martin, H., Schirutschke, H., Barnett, K., Hüther, J., Müller, P., Langer, T., Pluntke, T., Anding-Rost, K., Meistring, F., Stehr, T., Pietzonka, A., Escher, K., Cerny, S., Rothe, H., Pistrosch, F., Seidel, H., Paliege, A., Beige, J., Bast, I., Steglich, A., Gembardt, F., Kessel, F., Kröger, H., Arndt, P., Sradnick, J., Frank, K., Klimova, A., Mauer, R., Grählert, X., Anft, M., Blazquez-Navarro, A., Westhoff, T. H., Stervbo, U., Tonn, T., Babel, N., & Hugo, C.
Venue
The Lancet Regional Health - Europe
Publisher
Elsevier BV
Published
2021-10
Volume
9
Pages
100178
ISSN
2666-7762 (ISSN-L)
OpenAlex
W3186535828
Cited by
291
References
25
FWCI
19.77
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. https://app.cochat.ai/papers/10.1016/j.lanepe.2021.100178
The paper
Stumpf, J., Siepmann, T., Lindner, T., Karger, C., Schwöbel, J., Anders, L., Faulhaber-Walter, R., Schewe, J., Martin, H., Schirutschke, H., Barnett, K., Hüther, J., Müller, P., Langer, T., Pluntke, T., Anding-Rost, K., Meistring, F., Stehr, T., Pietzonka, A., . . . Hugo, C. (2021). Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. The Lancet Regional Health - Europe. https://doi.org/10.1016/j.lanepe.2021.100178

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.